Skip to main content
ILUMYA 100 mg/mL injection, solution by Sun Pharmaceutical Industries, Inc.
ILUMYA, 100 mg/mL, injection, solution Drug class: Interleukin-23 Antagonist. Available on prescription only. Listed by Sun Pharmaceutical Industries, Inc..
Prescription only

ILUMYA

tildrakizumab-asmn

Listed by Sun Pharmaceutical Industries, Inc.

Strength
100 mg/mL
Form
Injection, Solution
Route
Subcutaneous
Class
Interleukin-23 Antagonist

What it contains

  • Tildrakizumab 100 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Interleukin-23 Antagonist
Approval route BLA — biologic licence
NDC code 47335-177
FDA application BLA761067
RxNorm concept 2053453
Package sizes listed 4
Marketed since August 2018

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.